|
Reference #:
2001-098
Inventors/Contributors
Jeffrey L. Platt, M.D., Marilia I. Cascalho, M.D., Ph.D.
Description
Mayo Clinic researchers are developing a vaccine platform that addresses the challenge of viruses that rapidly modify their antigenic composition. The technology will generate immunity to antigenic variants of mutable viruses in anticipation. This novel approach has application to HIV, HCV and other mutable agents.
Patent Status
Pending |
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|
